- Condition: Stress Symptomatology
Interventions: Behavioral: Progressive Muscle Relaxation; Behavioral: Coherence Advantage
Sponsors: United States Naval Medical Center, San Diego; United States Naval Medical Center, San Diego
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Placebo; Drug: Vilazodone; Drug: Vilazodone
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified April 2012 - Condition: Depressive Disorder, Major
Interventions: Drug: LuAA21004; Drug: Duloxetine; Drug: Placebo
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Conditions: Major Depressive Disorder; Insulin Resistance
Interventions: Drug: Pioglitazone; Drug: Sugar Pill
Sponsors: Stanford University; Stanford University; National Institutes of Health (NIH)
Recruiting - verified March 2012 - Condition: Depression
Interventions: Drug: NSI-189 Phosphate; Drug: microcrystalline cellulose capsules
Sponsors: Neuralstem Inc.; Neuralstem Inc.
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Interventions: Drug: ALKS 5461; Drug: Placebo
Sponsors: Alkermes; Alkermes
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Interventions: Drug: AZD6765 iv; Drug: AZD6765 iv; Drug: Placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified February 2012 - Conditions: Bipolar Disorder; Major Depressive Disorder
Interventions: Behavioral: Enhanced Care; Behavioral: Family-Focused Treatment
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Stanford University; University of Colorado, Boulder
Recruiting - verified November 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Placebo; Drug: Vilazodone; Drug: Vilazodone; Drug: Citalopram
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Placebo; Drug: Vilazodone
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified February 2012 - Condition: Major Depressive Disorder
Interventions: Drug: cariprazine; Drug: cariprazine; Drug: placebo
Sponsors: Forest Laboratories; Forest Laboratories; Gedeon Richter Ltd.
Recruiting - verified March 2012 - Condition: Acute Depressive Episode
Interventions: Drug: Ramelteon SL; Drug: Ramelteon SL; Drug: Ramelteon SL; Drug: Placebo
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified March 2012 - Conditions: Anxiety; Depression
Intervention: Behavioral: Computerized Neurobehavioral Intervention
Sponsors: Stanford University; Stanford University
Recruiting - verified December 2011 - Condition: Depression Disorder, Major
Interventions: Drug: RO4995819; Drug: RO4995819; Drug: RO4995819; Drug: Placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Conditions: Depression; Pain; Dyspnea; Quality of Life
Interventions: Procedure: Symptom Management Service for Heart failure; Procedure: Usual cardiology care
Sponsors: University of California, San Francisco; University of California, San Francisco; Mount Sinai School of Medicine
Not yet recruiting - verified October 2011 - Condition: Depressive Symptoms
Interventions: Behavioral: Parent-Specific Depression Education and Motivation; Behavioral: General Depression Education-Motivation
Sponsors: University of California, Davis; University of California, Davis; Children's Miracle Network
Recruiting - verified October 2011 - Condition: Schizophrenia (Recent-onset)
Interventions: Drug: paliperidone palmitate; Drug: risperidone
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH); Ortho-McNeil Janssen Scientific Affairs, LLC
Not yet recruiting - verified October 2011 - Condition: Depression Disorder, Major
Interventions: Drug: RO4917523; Drug: RO4917523; Drug: Placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg; Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 30 mg; Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 50 mg; Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 70 mg; Drug: Antidepressant + Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate ); Drug: Antidepressant + Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: SPD489 (Lisdexamfetamine dimesylate ); Drug: Placebo
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Interventions: Drug: desvenlafaxine succinate sustained-release 50 mg/day; Drug: desvenlafaxine succinate sustained-release 100 mg/day; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Fibromyalgia
Interventions: Drug: Pregabalin; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Interventions: Drug: tasimelteon; Drug: placebo
Sponsors: Vanda Pharmaceuticals; Vanda Pharmaceuticals
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Intervention: Drug: Lurasidone
Sponsors: Sunovion; Sunovion
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Lurasidone 20 mg; Drug: Lurasidone 60 mg; Drug: Placebo
Sponsors: Sunovion; Sunovion
Not yet recruiting - verified November 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Placebo; Drug: Lu AA21004 10 mg; Drug: Lu AA21004 10 mg; Drug: Lu AA21004 20 mg
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified April 2012 - Condition: Major Depressive Disorder With Mixed Features
Interventions: Drug: Lurasidone; Drug: Placebo
Sponsors: Sunovion; Sunovion
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Augmenting: Antidepressant + Aripiprazole; Drug: Augmenting: Antidepressant + Bupropion-SR; Drug: Switching: Bupropion-SR
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified March 2012 - Conditions: Healthy Volunteers (Part 1); Major Depressive Disorder (Part 2)
Interventions: Drug: HT-2157; Drug: Placebo
Sponsors: Dart NeuroScience, LLC; Dart NeuroScience, LLC
Recruiting - verified August 2011 - Condition: Depression, Bipolar
Interventions: Drug: Placebo; Drug: Cariprazine; Drug: Cariprazine; Drug: Cariprazine
Sponsors: Forest Laboratories; Forest Laboratories; Gedeon Richter Ltd.
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: desvenlafaxine succinate sustained release; Drug: fluoxetine; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Intervention: Drug: DVS SR
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Intervention: Drug: DVS SR
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Desvenlafaxine Succinate Sustained-Release; Drug: Desvenlafaxine Succinate Sustained-Release; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Interventions: Device: NEST-1 (NeoSync EEG Synchronized TMS); Device: SHAM
Sponsors: NeoSync, Inc.; NeoSync, Inc.
Recruiting - verified May 2012 - Condition: Depression
Interventions: Drug: Duloxetine; Drug: Escitalopram; Drug: BMS-820836 Placebo; Drug: BMS-820836; Drug: BMS-820836; Drug: BMS-820836; Drug: BMS-820836
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified August 2011 - Condition: Treatment Outcome
Interventions: Drug: Lu AA21004; Drug: Escitalopram
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Condition: Depression
Interventions: Drug: Placebo matching with BMS-820836; Drug: BMS-820836; Drug: BMS-820836; Drug: BMS-820836
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified July 2011 - Conditions: Depressive Disorder; Depression; Depressive Disorder, Major; Mood Disorders; Mental Disorders
Interventions: Drug: OPC-34712 + ADT; Drug: Placebo + ADT; Drug: Placebo + ADT
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified July 2011 - Conditions: Depressive Disorder; Depression; Depressive Disorder, Major; Mood Disorders; Mental Disorders
Interventions: Drug: OPC-34712 + ADT; Drug: Placebo + ADT; Drug: Placebo + ADT
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified July 2011 - Condition: Major Depressive Disorder
Interventions: Drug: PNB01 fixed dose combination of pipamperone and citalopram; Drug: Citalopram; Drug: Pipamperone
Sponsors: PharmaNeuroBoost N.V.; PharmaNeuroBoost N.V.
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Behavioral: problem solving therapy; Drug: Sertraline
Sponsors: University of California, San Francisco; University of California, San Francisco; Leon J. Epstein Endowment
Recruiting - verified January 2012 - Conditions: Colorectal Neoplasms; Colonic Polyps; Colorectal Cancer
Intervention: Device: Technically Improved High Definition NBI Colonoscopy System
Sponsors: VA Palo Alto Health Care System; VA Palo Alto Health Care System; Kansas City Veteran Affairs Medical Center
Recruiting - verified January 2012 - Condition: Major Depressive Disorder
Interventions: Drug: LY2216684; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Depression
Interventions: Drug: Duloxetine; Drug: Placebo matching with BMS-820836; Drug: BMS-820836; Drug: Duloxetine; Drug: Placebo matching with Duloxetine
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified February 2012 - Conditions: Breast Cancer; Depression; Fatigue; Sleep Disorders
Interventions: Drug: metformin hydrochloride; Genetic: DNA analysis; Genetic: RNA analysis; Genetic: polymerase chain reaction; Genetic: polymorphism analysis; Genetic: reverse transcriptase-polymerase chain reaction; Other: enzyme-linked immunosorbent assay; Other: laboratory biomarker analysis; Other: questionnaire administration; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); National Surgical Adjuvant Breast and Bowel Project (NSABP); National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Bipolar
Interventions: Drug: Lurasidone; Drug: Placebo
Sponsors: Sunovion; Sunovion
Recruiting - verified April 2012 - Condition: Treatment Resistant Depression
Interventions: Drug: CX157; Drug: Placebo
Sponsors: CeNeRx BioPharma Inc.; CeNeRx BioPharma Inc.
Recruiting - verified October 2011 - Condition: Major Depression
Interventions: Behavioral: Online self-help course plus live follow-up if needed; Behavioral: Online + incentives Follow-up Group
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of Mental Health (NIMH)
Recruiting - verified April 2012 - Conditions: Major Depressive Disorder; Dysthymia Disorder
Interventions: Drug: Oxytocin; Drug: Placebo
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified September 2010 - Condition: Major Depressive Disorder
Intervention: Drug: Escitalopram
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified February 2012 - Condition: Major Depressive Disorder
Interventions: Device: rTMS; Device: Sham Device
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified April 2012 - Condition: Major Depressive Disorder (MDD)
Interventions: Drug: LY2216684; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Interventions: Drug: LY2216684; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Infant, Newborn; Hypoxia, Brain; Hypoxia-Ischemia, Brain; Encephalopathy, Hypoxic-Ischemic; Hypoxic-Ischemic Encephalopathy; Ischemic-Hypoxic Encephalopathy
Intervention: Procedure: Whole-body Cooling
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Research Resources (NCRR)
Recruiting - verified February 2012 - Condition: Major Depressive Disorder
Interventions: Drug: LY2216684; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Depression
Interventions: Behavioral: Family Focused Treatment (FFT); Behavioral: Individual Treatment (IP)
Sponsors: Boston University; Boston University; University of California, Los Angeles; National Institute of Mental Health (NIMH)
Recruiting - verified June 2011 - Conditions: Major Depression; Depression
Intervention: Behavioral: Self-help cognitive-behavioral online course
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of Mental Health (NIMH); Robert Wood Johnson Foundation
Recruiting - verified April 2012 - Conditions: Hepatitis C; Depression
Intervention: Other: Depression collaborative care model
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified December 2011 - Condition: Spinal Cord Injuries
Intervention: Behavioral: Vocational Rehabilitation
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified May 2012 - Condition: Depression
Intervention: Drug: Armodafinil
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Condition: Stress Disorders, Post-Traumatic
Intervention: Behavioral: EFT (Emotional Freedom Techniques)
Sponsors: Soul Medicine Institute; Soul Medicine Institute
Recruiting - verified June 2011 - Conditions: Parkinson's Disease; Depression
Intervention: Device: Repetitive transcranial magnetic stimulation (rTMS)
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; University of California, Los Angeles; University of Florida; University Health Network, Toronto; The Cleveland Clinic; Michael J. Fox Foundation for Parkinson's Research
Recruiting - verified January 2012 - Conditions: Smoking Cessation; Depression
Interventions: Drug: varenicline; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Depression
Interventions: Drug: Armodafinil; Drug: Armodafinil; Drug: Placebo
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Condition: Depression
Intervention: Drug: Pramipexole
Sponsors: Stanford University; Stanford University
Recruiting - verified August 2010 - Condition: Major Depressive Disorder
Interventions: Behavioral: Mindfulness-Based Cognitive Therapy (MBCT); Behavioral: Health-Enhancement Program (HEP)
Sponsors: University of California, San Francisco; University of California, San Francisco; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified March 2012 - Conditions: Depressive Symptoms; Substance-related Disorders; Posttraumatic Stress Disorders
Interventions: Behavioral: ICBT: Integrated Cognitive Behavioral Therapy; Behavioral: CPT-M: Cognitive Processing Therapy-Modified
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified December 2011 - Condition: Major Depressive Disorder
Interventions: Behavioral: Mindfulness Based Cognitive Therapy; Behavioral: Health Enhancement Program and medication management
Sponsors: University of California, San Francisco; University of California, San Francisco; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified April 2012 - Conditions: Bipolar; Depression
Intervention: Drug: lurasidone
Sponsors: Sunovion; Sunovion
Recruiting - verified April 2012 - Conditions: Convulsion, Non-Epileptic; Conversion Disorder; Depression; Stress Disorders, Post-Traumatic; Dissociative Disorders
Interventions: Drug: sertraline; Behavioral: CBT for NES; Other: Med+CBT; Other: Standard Care
Sponsors: Rhode Island Hospital; Rhode Island Hospital; American Epilepsy Society; Epilepsy Foundation; University of Cincinnati; Stanford University
Recruiting - verified July 2011 - Conditions: Depression; Postpartum Depression
Intervention: Behavioral: Mothers and babies Internet course and PPD informational brochure
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of Mental Health (NIMH)
Recruiting - verified January 2012 - Condition: Depression
Intervention: Behavioral: Lifestyle Counseling with Emotional Freedom Techniques (EFT)
Sponsors: Soul Medicine Institute; Soul Medicine Institute
Recruiting - verified June 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Escitalopram; Drug: Sertraline; Drug: Venlafaxine XR
Sponsors: BRC Operations Pty. Ltd.; BRC Operations Pty. Ltd.
Recruiting - verified March 2012 - Conditions: Psychotic Depression; Major Depression With Psychotic Features; Psychosis
Interventions: Drug: mifepristone; Drug: placebo
Sponsors: Corcept Therapeutics; Corcept Therapeutics
Recruiting - verified February 2012 - Conditions: Infant, Newborn; Hypoxia, Brain; Hypoxia-Ischemia, Brain; Encephalopathy, Hypoxic-Ischemic; Hypoxic-Ischemic Encephalopathy; Ischemic-Hypoxic Encephalopathy
Interventions: Procedure: Hypothermia; Procedure: Normothermic Control
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Research Resources (NCRR)
Recruiting - verified September 2011 - Condition: Depression
Interventions: Behavioral: Problem-solving therapy (PST); Behavioral: Case management (CM)
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University; National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Condition: Schizophrenia
Interventions: Behavioral: Cognitive remediation; Behavioral: Health behavior training; Drug: Risperidone, administered orally; Drug: Risperidone, administered via injection; Behavioral: Individual Placement and Support
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH); Ortho-McNeil Janssen Scientific Affairs, LLC
Recruiting - verified October 2011 - Condition: Schizophrenia
Interventions: Behavioral: Group Skills Training and Psychoeducation; Behavioral: Individual Case Management; Drug: Oral Risperidone; Drug: Risperidone in Long-Acting Injectable Form (Consta)
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH); Ortho-McNeil Janssen Scientific Affairs, LLC
Recruiting - verified October 2011 - Condition: Major Depressive Disorder
Intervention: Drug: Sertraline (drug)
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institutes of Health (NIH)
Recruiting - verified January 2012
 |
Join Clinical Trials in California for Depression |
